{"id":670,"date":"2023-01-12T04:55:15","date_gmt":"2023-01-12T04:55:15","guid":{"rendered":"https:\/\/pkudsehcp-dev-001.azurewebsites.net\/es-us\/?page_id=670"},"modified":"2024-09-17T08:19:36","modified_gmt":"2024-09-17T08:19:36","slug":"metas-del-manejo","status":"publish","type":"page","link":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/","title":{"rendered":"Metas del Manejo"},"content":{"rendered":"<div id=\"acf-block-63f65a277c913\" class=\"hero hero-no-overlay\">\n            <div class=\"hero-background-image hero-background-image-desktop\" style=\"background-image: url(https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/01\/PKU_Tree_DSE_Website_Interior_2022_v1_RGB_FIN.jpg?v=0.90);\"><\/div>\n\t    <div class=\"hero-background-image hero-background-image-mobile\" style=\"background-image: url(https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/01\/PKU_Tree_DSE_Website_Interior_2022_v1_RGB_FIN.jpg?v=0.90);\"><\/div>\n    \t<div class=\"overlay\"><\/div>\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"hero-content\">\n\t\t\t    \t\t\t\t\t\t\t\t\t\t\t\t    <h1>La reducci\u00f3n de fenilalanina (Phe) es fundamental para el tratamiento<sup>1<\/sup>\n<\/h1>\n\t\t\t\t\t\t\t\t\t\t\t\t\n                <p class=\"inline-buttons\">\n                                                        <\/p>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n<div id=\"Managing-PKU\" class=\"block split-content equal-bias bg-band bg-band-white block-zero-top block-zero-bottom\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                <h2>Control de la fenilcetonuria (PKU)<\/h2>\n<p>Se adquiri\u00f3 un considerable conocimiento en relaci\u00f3n con la mejor\u00eda de los s\u00edntomas neurol\u00f3gicos y neuro-psicosociales asociados con una reducci\u00f3n de fenilalanina (Phe).<sup>2,3<\/sup><\/p>\n<ul>\n<li>Una Phe elevada se correlaciona con la severidad de los s\u00edntomas neuropsicol\u00f3gicos, que generalmente mejoran con la reducci\u00f3n de Phe<sup>2<\/sup><\/li>\n<li>Evidencias cl\u00ednicas emergentes sugieren que se pueden obtener beneficios adicionales cuando la Phe est\u00e1 por debajo de los niveles recomendados<sup>4,5<\/sup><\/li>\n<\/ul>\n                                                                                    <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                                                                                                                                                                                                    \n                                                                                                                \n                                                                                                                \n                                    \n                                    <figure>\n                                        <div class=\"image image-responsive image-rounded\">\n                                                                                            <div class=\"image-desktop\">\n                                                    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/02\/lower_phe_new.svg\" alt=\"Icono de control metab\u00f3lico\" \/>                                                <\/div>\n                                                <div class=\"image-mobile\">\n                                                    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/01\/phe_icon_-e1679409146117.png?v=0.90\" alt=\"Icono de phe baja\" \/>                                                <\/div>\n                                                                                    <\/div>\n                                                                            <\/figure>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"Guidlines\" class=\"block split-content equal-bias bg-band bg-band-alternative block-zero-top block-zero-bottom\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                <h2>Las gu\u00edas de la ACMG recomiendan mantener de por vida los niveles de fenilalanina en sangre dentro de un rango de 120-360 \u03bcmol\/L (2-6 mg\/dL) en pacientes de todas las edades\u00b2.<\/h2>\n                                                                                                                                <ul>\n<li>El tratamiento debe iniciarse lo m\u00e1s pronto posible y debe mantenerse durante toda la vida<\/li>\n<li>Cualquier combinaci\u00f3n de tratamientos que ayude a mantener los niveles de Phe en sangre dentro del rango recomendado es adecuada<\/li>\n<\/ul>\n<p>Consulte el art\u00edculo completo de las directrices americanas de la American College of Medical Genetics and Genomics (ACMG) sobre el diagn\u00f3stico y tratamiento de la fenilcetonuria <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24385074\/\" target=\"_blank\" rel=\"noopener\">aqu\u00ed<\/a><\/p>\n                                                                                    <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                                                                                                                                                                                                    \n                                                                                                                \n                                                                                                                \n                                    \n                                    <figure>\n                                        <div class=\"image image-responsive image-rounded\">\n                                                                                            <div class=\"image-desktop\">\n                                                    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2024\/09\/4.2_Phe-Levels-Icon.svg\" alt=\"\" \/>                                                <\/div>\n                                                <div class=\"image-mobile\">\n                                                    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2024\/09\/phe_360_icon_new2.svg\" alt=\"\" \/>                                                <\/div>\n                                                                                    <\/div>\n                                                                            <\/figure>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"50%\" class=\"block split-content equal-bias bg-band bg-band-white block-zero-top block-zero-bottom\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                                                                                                                                                                                                    \n                                    \n                                                                                                                \n                                    \n                                    <figure>\n                                        <div class=\"image image-rounded\">\n                                                                                            <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2024\/09\/50percent_gfx_ES_new2.svg\" alt=\"\" \/>                                                                                    <\/div>\n                                                                            <\/figure>\n                                                                                    <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                <h2>Es importante volver a comprometer a los adultos j\u00f3venes y adultos con PKU de los que se perdi\u00f3 el seguimiento (LTFU)*<\/h2>\n<ul>\n<li>Los adultos LTFU tienen un control y resultados pobres de la PKU en comparaci\u00f3n con los pacientes que frecuentan la cl\u00ednica regularmente<sup>2<\/sup><\/li>\n<li>Las directivas de ACMG afirman que los pacientes que interrumpieron la terapia (diet\u00e9tica o medicamentosa) probablemente observar\u00e1n mejoras en sus s\u00edntomas si regresan al tratamiento<sup>2<\/sup><\/li>\n<\/ul>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277e990\" class=\"block wrapped-content block-zero-top block-zero-bottom\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"What-experts-say\" class=\"block wrapped-content block-tight-top block-tight-bottom\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-63f65a277e9ac\" class=\"block-wysiwyg\">\n            <h2>Qu\u00e9 dicen los especialistas sobre volver a comprometer a los pacientes perdidos durante el seguimiento (LTFU)<sup>6<\/sup><\/h2>\n    <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277e9bc\" class=\"block cards cards-3-col block-tight-top block-tight-bottom\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"cards-title\">\n\t\t\t    \t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"cards-wrapper\">\n\t\t\t    \n<div id=\"acf-block-63f65a277e9cc\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Aseg\u00farese de que los pacientes tengan conocimiento sobre las directivas actuales de tratamiento de PKU<\/h5>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277e9db\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Comunicar cualquier nueva opci\u00f3n de tratamiento y dieta para PKU<\/h5>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277e9ec\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Formalizar enfoques para rastrear y\/o identificar pacientes adultos LTFU<\/h5>\n                                                                                    <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277e9fe\" class=\"block cards cards-3-col block-tight-top\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"cards-title\">\n\t\t\t    \t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"cards-wrapper\">\n\t\t\t    \n<div id=\"acf-block-63f65a277ea0b\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Priorizar pacientes adultos LTFU motivados<\/h5>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277ea19\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Evaluar nuevos enfoques de contacto con pacientes adultos LTFU<\/h5>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277ea26\" class=\"card\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                \n                                                                                                            <h5>Formalizar enfoques para rastrear y\/o identificar pacientes adultos con p\u00e9rdida de seguimiento (LTFU)<\/h5>\n                                                                                    <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"Expert-opinions\" class=\"block wrapped-content bg-band bg-band-white block-zero-top block-zero-bottom\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-63f65a277ea3f\" class=\"block-wysiwyg\">\n            <h2>Opiniones de especialistas para manejar el regreso de pacientes LTFU con PKU<sup>8<\/sup><\/h2>\n    <\/div>\n\n<figure id=\"acf-block-63f65a277ea51\">\n    <div class=\"image image-responsive image-rounded image-align-left\">\n                    <div class=\"image-desktop\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2024\/09\/icons_ES_New2.svg\" alt=\"\" \/>\t\t\t<\/div>\n\t\t\t<div class=\"image-mobile\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2024\/09\/icons_Mobile_ES_New2.svg\" alt=\"\" \/>\t\t\t<\/div>\n            <\/div>\n            <figcaption><p><small>*Basado en 2 publicaciones que resumen los resultados de un grupo de 8 adultos LTFU con PKU, observados por 10 m\u00e9dicos, seguido de una sesi\u00f3n de asesoramiento con un grupo de m\u00e9dicos, en una encuesta on-line con 55 cl\u00ednicas de PKU de EEUU y una reuni\u00f3n de especialistas con 15 miembros de cl\u00ednicas de PKU de EEUU. Financiado por BioMarin.<\/small><\/p>\n<\/figcaption>\n    <\/figure>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277ea62\" class=\"block wrapped-content block-tight-top block-tight-bottom\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-63f65a277ea6f\" class=\"block-wysiwyg\">\n            <h2>Conozca m\u00e1s sobre PKU<\/h2>\n    <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277ea7f\" class=\"block cards cards-2-col block-tight-top block-tight-bottom\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"cards-title\">\n\t\t\t    \t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"cards-wrapper\">\n\t\t\t    \n<div id=\"acf-block-63f65a277ea91\" class=\"card card-product card-fixed-button card-centered\" data-muted-autoplay=\"false\">\n    \t    \n\n                    <img decoding=\"async\" class=\"card-image\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/01\/management_icon_v2.svg\" alt=\"Icono de opciones de gesti\u00f3n de PKU\" \/>        \n\t    <div class=\"card-content\">\n                            <h4>Conociendo las opciones de tratamiento de PKU\n<\/h4>\n        \n                                                                                                            <p>En combinaci\u00f3n con una dieta restringida en fenilalanina (Phe), existen opciones farmacol\u00f3gicas que pueden ayudar a reducir los niveles sangu\u00edneos de Phe en pacientes con PKU.<\/p>\n                                                                                                                                                                                                                                                                        \n                                                                                        <\/div>\n                                <div class=\"card-actions\">\n                            \n                            <p><a class=\"button\" href=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/opciones-de-tratamiento-de-la-pku\/\" target=\"_self\">Conozca m\u00e1s<\/a><\/p>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277eaa7\" class=\"card card-product card-fixed-button card-centered\" data-muted-autoplay=\"false\">\n    \t    \n\n                    <img decoding=\"async\" class=\"card-image\" src=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-content\/uploads\/sites\/6\/2023\/01\/Phe_icon.svg\" alt=\"Icono de control metab\u00f3lico\" \/>        \n\t    <div class=\"card-content\">\n                            <h4>Por qu\u00e9 el control metab\u00f3lico es tan importante<sup>9,10<\/sup>\n<\/h4>\n        \n                                                                                                                                                                                                                                                                                    \n                                                                                        <\/div>\n                                <div class=\"card-actions\">\n                            \n                            <p><a class=\"button\" href=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/desafios-de-pku\/\" target=\"_self\">Conozca m\u00e1s<\/a><\/p>\n                                                                                    <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"Mant\u00e9ngase-actualizado\" class=\"block hcp-sign-up-form\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                            <h2>Mant\u00e9ngase actualizado con la informaci\u00f3n m\u00e1s recientes sobre PKU\n<\/h2>\n                        <div class=\"block form-box\">\n                                    <p>Reg\u00edstrese abajo para entrar en contacto con un representante de BioMarin, conozca m\u00e1s sobre los pr\u00f3ximos eventos y noticias sobre PKU o solicitar una conversaci\u00f3n entre pares.<\/p>\n<p><strong>* Campos obligatorios<\/strong><\/p>\n                \n                <form id=\"hcp-sign-up\" name=\"Stay connected with the latest PKU information\">\n                    <div class=\"form-item check-item\">\n                        <input type=\"checkbox\" id=\"connect-local-rep\" name=\"connect_local_rep\">\n                        <label for=\"connect-local-rep\">Con\u00e9ctese con un representante local de BioMarin<\/label>\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <label for=\"first-name\">Primer nombre<span class=\"required\">*<\/span><\/label>\n                        <input class=\"text\" id=\"first-name\" type=\"text\" required\n                        data-pristine-required-message=\"Ingrese su primer nombre.\">\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <label for=\"last-name\">Apellido<span class=\"required\">*<\/span><\/label>\n                        <input class=\"text\" id=\"last-name\" type=\"text\" required\n                        data-pristine-required-message=\"Ingrese su apellido.\">\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <label for=\"medical-speciality\">Especialidad<span class=\"required\">*<\/span><\/label>\n                        <select class=\"text\" id=\"medical-speciality\" required\n                        data-pristine-required-message=\"Seleccione su especialidad m\u00e9dica.\">\n                            <option value=\"\">Por favor, seleccione su especialidad m\u00e9dica<\/option>\n                            <option value=\"Anesthesiology\">Anestesiolog\u00eda<\/option>\n                            <option value=\"Audiology\">Audiolog\u00eda<\/option>\n                            <option value=\"Behavioral Neurology &#038; Neuropsychiatry\">Neurolog\u00eda del Comportamiento y Neuropsiquiatr\u00eda<\/option>\n                            <option value=\"Biology\">Biolog\u00eda<\/option>\n                            <option value=\"Biomedical Engineering\">Ingenier\u00eda Biom\u00e9dica<\/option>\n                            <option value=\"Cardiology\">Cardiolog\u00eda<\/option>\n                            <option value=\"Clinical Biochemical Genetics\">Gen\u00e9tica Bioqu\u00edmica Cl\u00ednica<\/option>\n                            <option value=\"Dentistry and Odontology\">Odontolog\u00eda<\/option>\n                            <option value=\"Dermatology\">Dermatolog\u00eda<\/option>\n                            <option value=\"Diagnostic Radiology\">Radiolog\u00eda diagn\u00f3stica<\/option>\n                            <option value=\"Electoencephalography\">Electroencefalograf\u00eda<\/option>\n                            <option value=\"Endocrinology, Diabetes &#038; Metabolism\">Endocrinolog\u00eda, Diabeter y Metabolismo<\/option>\n                            <option value=\"ENT\/ Otorhinolaryngologist\">Otorrinolaring\u00f3logo<\/option>\n                            <option value=\"Epileptology\">Epileptolog\u00eda<\/option>\n                            <option value=\"Gastroenterology\">Gastroenterolog\u00eda<\/option>\n                            <option value=\"General Practice\/Family\">Cl\u00ednica general\/familiar<\/option>\n                            <option value=\"Genetics\">Gen\u00e9tica<\/option>\n                            <option value=\"Hearing and Speech\">Terapia del lenguaje<\/option>\n                            <option value=\"Hematology\">Hematolog\u00eda<\/option>\n                            <option value=\"Hematology&#038;Oncology\">Hematolog\u00eda y Oncolog\u00eda<\/option>\n                            <option value=\"Hepatology\">Hepatolog\u00eda<\/option>\n                            <option value=\"Infectious Diseases\">Enfermedades infecciosas<\/option>\n                            <option value=\"Intensive Care\">Tratamiento intensivo<\/option>\n                            <option value=\"Internal Medicine\">Medicina Interna<\/option>\n                            <option value=\"Kinesiology\">Kinesiolog\u00eda<\/option>\n                            <option value=\"Laboratory Management\">Gesti\u00f3n de laboratorio<\/option>\n                            <option value=\"Medical Student\">Estudiante de medicina<\/option>\n                            <option value=\"Neonatology\">Neonatolog\u00eda<\/option>\n                            <option value=\"Nephrology\">Nefrolog\u00eda<\/option>\n                            <option value=\"Neurology\">Neurolog\u00eda<\/option>\n                            <option value=\"Neuromuscular Medicine\">Medicina neuromuscular<\/option>\n                            <option value=\"Nutrition, Metabolic\">Nutrici\u00f3n metab\u00f3lica<\/option>\n                            <option value=\"Nutritionist\">Nutricionista<\/option>\n                            <option value=\"Obstetrics\">Obstetricia<\/option>\n                            <option value=\"Occupation Health\">Salud ocupacional<\/option>\n                            <option value=\"Oncology\">Oncolog\u00eda<\/option>\n                            <option value=\"Ophthalmology\">Oftalmolog\u00eda<\/option>\n                            <option value=\"Orthopedics\">Ortoped\u00eda<\/option>\n                            <option value=\"Paliative\/Hospice\">Paliativo<\/option>\n                            <option value=\"Pediatric Allergy\/Immunology\">Alergia\/Inmunolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Anesthesiology\">Anestesiolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Cardiology\">Cardiolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Dentistry\">Odont\u00f3logo pedi\u00e1trico<\/option>\n                            <option value=\"Pediatric Endocrinology\">Endocrinolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Endocrinology, Diabetes &#038; Metabolism\">Endocrinolog\u00eda Pedi\u00e1trica, Diabetes y Metabolismo<\/option>\n                            <option value=\"Pediatric ENT\">Otorrinolaringolog\u00eda pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Gastroenterology\">Gastroenterolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Gastroenterology &#038; Metabolism\">Gastroenterolog\u00eda y metabolismo pedi\u00e1tricos<\/option>\n                            <option value=\"Pediatric Genetics\">Gen\u00e9tica pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Hematology\">Hematolog\u00eda pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Hematology-Oncology\">Hematolog\u00eda-Oncolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Metabolism\">Metabolismo pedi\u00e1trico<\/option>\n                            <option value=\"Pediatric Neurology\">Neurolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Neurosurgery\">Neurocirug\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Oncology\">Oncolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Ophthalmology and Strabismus Specialist\">Especialista en oftalmolog\u00eda pedi\u00e1trica y estrabismo<\/option>\n                            <option value=\"Pediatric Orthopedics\">Ortopedia pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Pneumology\">Neumolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Radiology\">Radiolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatric Rheumatology\">Reumatolog\u00eda Pedi\u00e1trica<\/option>\n                            <option value=\"Pediatrics\">Pediatr\u00eda<\/option>\n                            <option value=\"Phonoaudiology\">Terapia del lenguaje<\/option>\n                            <option value=\"Physiatry\">Fisiatr\u00eda<\/option>\n                            <option value=\"Physician Assistant\">M\u00e9dico asistente<\/option>\n                            <option value=\"Physiotherapy\">Fisioterapia<\/option>\n                            <option value=\"Primary Care\">Atenci\u00f3n primaria<\/option>\n                            <option value=\"Psychology\/Psychiatry\">Psicolog\u00eda\/Psiquiatr\u00eda<\/option>\n                            <option value=\"Pulmonology\">Neumolog\u00eda<\/option>\n                            <option value=\"Radiology (MRI imaging)\">Radiolog\u00eda<\/option>\n                            <option value=\"Research\">Investigador<\/option>\n                            <option value=\"Rheumatology\">Reumatolog\u00eda<\/option>\n                            <option value=\"Surgery\">Cirug\u00eda<\/option>\n                            <option value=\"Traumatology\">Traumatolog\u00eda<\/option>\n                            <option value=\"Other\">Otro<\/option>\n                        <\/select>\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <label for=\"email\">Direcci\u00f3n de e-mail<span class=\"required\">*<\/span><\/label>\n                        <input class=\"text\" id=\"email\" type=\"email\" required\n                        data-pristine-required-message=\"Ingrese su direcci\u00f3n de e-mail.\"\n                        data-pristine-email-message=\"Este campo requiere una direcci\u00f3n de e-mail v\u00e1lida.\">\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <label for=\"country\">Pa\u00eds<span class=\"required\">*<\/span><\/label>\n                        <select class=\"text\" id=\"country\" required\n                        data-pristine-required-message=\"Selecciona tu pais.\">\n                            <option value=\"\">Por favor, seleccione su pa\u00eds<\/option>\n                            <option value=\"ARGENTINA\">Argentina<\/option>\n                            <option value=\"BOLIVIA\">Bolivia<\/option>\n                            <option value=\"CHILE\">Chile<\/option>\n                            <option value=\"COLOMBIA\">Colombia<\/option>\n                            <option value=\"COSTA RICA\">Costa Rica<\/option>\n                            <option value=\"ECUADOR\">Ecuador<\/option>\n                            <option value=\"EL SALVADOR\">El Salvador<\/option>\n                            <option value=\"GUATEMALA\">Guatemala<\/option>\n                            <option value=\"MEXICO\">M\u00e9xico<\/option>\n                            <option value=\"NICARAGUA\">Nicar\u00e1gua<\/option>\n                            <option value=\"PANAMA\">Panam\u00e1<\/option>\n                            <option value=\"PARAGUAY\">Paraguay<\/option>\n                            <option value=\"PERU\">Peru<\/option>\n                            <option value=\"URUGUAI\">Uruguai<\/option>\n                            <option value=\"OTHER\">Otro<\/option>\n                        <\/select>\n                    <\/div>\n\n                    <div class=\"form-item check-item\">\n                        <input type=\"checkbox\" id=\"accept-ts-cs\" name=\"accept_ts_cs\" required\n                        data-pristine-required-message=\"Por favor, acepte los t\u00e9rminos de uso.\">\n                        <label for=\"accept-ts-cs\">Al enviar su informaci\u00f3n y confirmar su registro, usted declara, para los debidos efectos legales, que la informaci\u00f3n proporcionada es verdadera, siendo responsable de cualquier inexactitud, falsedad, error y cualesquiera consecuencias que de ello se deriven y aceptando la <a href=\"https:\/\/www.biomarin.com\/data-privacy-center\/\" target=\"_blank\">Pol\u00edtica de Privacidad de BioMarin<\/a> y los <a href=\"https:\/\/medinfoterms.com\/\" target=\"_blank\">T\u00e9rminos de Uso<\/a> y acepta el procesamiento de sus Datos personales seg\u00fan lo establecido en el mismo, incluido que sus Datos personales se almacenar\u00e1n en bases de datos de BioMarin ubicadas, entre otras, en Am\u00e9rica Latina, Europa y\/o Estados Unidos. De acuerdo con la Pol\u00edtica de Privacidad de BioMarin, sus Datos Personales se mantendr\u00e1n seguros, de acuerdo con las leyes y regulaciones aplicables, y podr\u00e1n usarse para (i) invitarlo a participar en programas que BioMarin desarrolla por s\u00ed mismo y\/o junto con sus socios, (ii) realizar actividades relacionadas con el objeto social de BioMarin, (iii) realizar estudios epidemiol\u00f3gicos e investigaciones de resultados, (iv) comunicar informaci\u00f3n sobre enfermedades del portafolio de BioMarin, (v) comunicar informaci\u00f3n sobre los productos de BioMarin a profesionales de la salud a trav\u00e9s de nuestros representantes de ventas o equipo m\u00e9dico, nuestros sitios web, correo electr\u00f3nico, centros de llamadas, correo postal y otros canales, incluidas comunicaciones y otras promociones de marketing, seg\u00fan corresponda, (vi) realizar simposios, conferencias y otros programas educativos y cient\u00edficos, de BioMarin mismo o de terceros; y (vii) realizar estudios de mercado. Si tiene alguna pregunta sobre el procesamiento de sus datos personales o desea ejercer sus derechos, comun\u00edquese con BioMarin a trav\u00e9s del correo electr\u00f3nico <a href=\"mailto:LATAMDataPrivacy@ bmrn.com\">LATAMDataPrivacy@bmrn.com<\/a>.<span class=\"required\">*<\/span><\/label>\n                    <\/div>\n\n                    <div class=\"form-item\">\n                        <input type=\"submit\" class=\"button\" value=\"Enviar\">\n                    <\/div>\n                <\/form>\n                <form id=\"mktoForm_3470\" style=\"display:none;\"><\/form>\n            <\/div>\n\n            <div class=\"block form-success-confirmation\" style=\"display:none;\">\n                                    <h3>\u00a1Muchas gracias!<\/h3>\n<p>En breve nos pondremos en contacto con informaci\u00f3n adicional.<\/p>\n                                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-63f65a277eade\" class=\"block references\">\n    <div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t    \t\t\t    <h4>Referencias:\n<\/h4>\n\t\t\t\t\t\t                <ol>\n                                                                                                                        <li><span>Ceberio L, Hermida \u00c1, Venegas E, et al. Phenylketonuria in the adult patient. Expert Opin Orphan Drugs. 2019;7(6):265-276.\n<\/span><\/li>\n                                                                                                                                                <li><span>Vockley J, Andersson HC, Antshel KM, et al. American College of Medical Genetics and Genomics Therapeutic Committee. Phenylalanine hydroxylase deficiency: diagnosis and management guidelines.\u00a0Genet Med. 2014;16(2):188-200.\n<\/span><\/li>\n                                                                                                                                                <li><span>Bilder DA, Noel JK, Baker ER, et al. Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria.\u00a0Dev Neuropsychol. 2016;41(4):245-260.\n<\/span><\/li>\n                                                                                                                                                <li><span>Evinc SG, Pektas E, Foto-\u00d6zdemir D, et al. Cognitive and behavioral impairment in mild hyperphenylalaninemia.\u00a0Turk J Pediatr.\u00a02018;60(6):617-624.\n<\/span><\/li>\n                                                                                                                                                <li><span>Jahja R, Huijbregts S, de Sonneville LMJ, van der Meere JJ, van Spronsen FJ. Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria.\u00a0J Pediatr. 2014;164(4):895-899.\n<\/span><\/li>\n                                                                                                                                                <li><span>Berry SA, Brown C, Grant M, et al. Newborn screening 50 years later: access issues faced by adults with PKU.\u00a0Genet Med. 2012:1-9.\n<\/span><\/li>\n                                                                                                                                                <li><span>Beazer J, Breck J, Eggerding C, et al. the PKU Lost to Follow-up Recommendations Group. Strategies to engage lost to follow-up patients with phenylketonuria in the United States: best practice recommendations.\u00a0Mol Genet Metab Rep. 2020;23:100571. doi: 10.1016\/j.ymgmr.2020.100571.\n<\/span><\/li>\n                                                                                                                                                <li><span>Thomas J, Nguyen-Driver M, Bausell H, Breck J, Zambrano J, Birardi V. Strategies for successful long-term engagement of adults with phenylalanine hydroxylase deficiency returning to the clinic.\u00a0J Inborn Errors Metab Screen. 2017;5:1-9.\n<\/span><\/li>\n                                                            <\/ol>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-670","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe<\/title>\n<meta name=\"description\" content=\"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe\" \/>\n<meta property=\"og:description\" content=\"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin PKU DSE HCP ES-LA\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-17T08:19:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/metas-del-manejo\\\/\",\"url\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/metas-del-manejo\\\/\",\"name\":\"Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/#website\"},\"datePublished\":\"2023-01-12T04:55:15+00:00\",\"dateModified\":\"2024-09-17T08:19:36+00:00\",\"description\":\"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/metas-del-manejo\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/metas-del-manejo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/metas-del-manejo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metas del Manejo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/#website\",\"url\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/\",\"name\":\"BioMarin PKU DSE HCP ES-LA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hcp.biomarin.com\\\/es-la\\\/pku\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe","description":"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/","og_locale":"es_ES","og_type":"article","og_title":"Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe","og_description":"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible","og_url":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/","og_site_name":"BioMarin PKU DSE HCP ES-LA","article_modified_time":"2024-09-17T08:19:36+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/","url":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/","name":"Manejo de la fenilcetonuria (PKU) l Reducci\u00f3n de las concentraciones de Phe","isPartOf":{"@id":"https:\/\/hcp.biomarin.com\/es-la\/pku\/#website"},"datePublished":"2023-01-12T04:55:15+00:00","dateModified":"2024-09-17T08:19:36+00:00","description":"La reducci\u00f3n de los niveles de Phe se reconoce como la principal estrategia para el manejo de la fenilcetonuria (PKU). Las directivas de los EEUU recomiendan iniciar tratamiento lo antes posible","breadcrumb":{"@id":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hcp.biomarin.com\/es-la\/pku\/metas-del-manejo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hcp.biomarin.com\/es-la\/pku\/"},{"@type":"ListItem","position":2,"name":"Metas del Manejo"}]},{"@type":"WebSite","@id":"https:\/\/hcp.biomarin.com\/es-la\/pku\/#website","url":"https:\/\/hcp.biomarin.com\/es-la\/pku\/","name":"BioMarin PKU DSE HCP ES-LA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hcp.biomarin.com\/es-la\/pku\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/pages\/670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/comments?post=670"}],"version-history":[{"count":300,"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/pages\/670\/revisions"}],"predecessor-version":[{"id":4707,"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/pages\/670\/revisions\/4707"}],"wp:attachment":[{"href":"https:\/\/hcp.biomarin.com\/es-la\/pku\/wp-json\/wp\/v2\/media?parent=670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}